Key result
Recurrent venous thromboembolism has a cumulative recurrence of 40% at 10 years, and ipsilateral recurrence almost quadruples the chance of developing postthrombotic signs and symptoms.
Answers are grounded in this paper and cite their sources.
Recurrent venous thromboembolism carries a high morbidity burden with a 40% cumulative recurrence rate at 10 years, requiring tailored management strategies.
Recurrent venous thromboembolism is a significant problem leading to increased morbidity and mortality. It has a high impact on patients' quality of life and imposes a great financial burden on society. Cumulative recurrence has been reported as 40% at 10 years, while the chance of developing postthrombotic signs and symptoms in the lower extremities almost quadruples when ipsilateral. There is also a higher chance of developing pulmonary hypertension. Important factors for recurrence are unprovoked episodes of deep vein thrombosis, malignancy and older age. The evidence for other factors is controversial. Accurate diagnosis and treatment tailored to the patients' history, thrombotic events and risk factors are necessary to optimize management and prevent recurrence.
No takes yet. Share an insight, caveat, or question.
Labropoulos et al. (2010) conducted a review in Recurrent venous thromboembolism. Recurrent venous thromboembolism was evaluated. Recurrent venous thromboembolism has a cumulative recurrence of 40% at 10 years, and ipsilateral recurrence almost quadruples the chance of developing postthrombotic signs and symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: